S. Nordkamp

Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)

E. Verdaasdonk, H. Grabsch, J. Monson, 2021, BJS open.

MRI tumour regression grade in locally recurrent rectal cancer.

J. Cnossen, J. Burger, G. Nieuwenhuijzen, 2022, BJS open.

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training

E. D. Geijsen, E. Verdaasdonk, J. Plate, 2022, Insights into Imaging.

Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline.

Dwight A. Larson, P. Sutton, Ionut Negoi, 2022, The British journal of surgery.

Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.

J. Cnossen, J. Burger, G. Nieuwenhuijzen, 2022, The British journal of surgery.

Development of a consensus-based delineation guideline for locally recurrent rectal cancer.

C. Marijnen, H. Ceha, H. Rutten, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?

H. Rutten, J. V. van Rees, J. Burger, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting

E. D. Geijsen, E. Verdaasdonk, L. Kroese, 2023, Annals of Surgical Oncology.

Implementation of an Enhanced Recovery after Surgery Protocol in Advanced and Recurrent Rectal Cancer Patients after beyond Total Mesorectal Excision Surgery: A Feasibility Study

G. Nieuwenhuijzen, J. Bloemen, S. Ketelaers, 2023, Cancers.

Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.

J. Cnossen, J. Burger, G. Nieuwenhuijzen, 2023, The British journal of surgery.